uniQure N.V. (QURE) Downgraded to Equal-Weight by Barclays

Market Context

uniQure N.V. operates in the Healthcare sector. The stock currently trades at $22.93 with a market capitalization of $1.1B.

Analyst downgrades can weigh on a stock in the short term as institutional investors who follow Barclays's research adjust their positions. However, downgrades also sometimes create buying opportunities if the market overreacts to the rating change. The reasoning behind the downgrade matters more than the rating itself.

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for uniQure N.V.

Among the 10 most recent ratings: 8 Buy, 2 Hold, 0 Sell.

Date	Firm	Rating	Price Target
Oct 05, 2026	Barclays	Equal-Weight	N/A
Oct 02, 2026	RBC Capital	Outperform	N/A
Sep 30, 2026	Goldman Sachs	Neutral	N/A
Sep 02, 2026	William Blair	Outperform	N/A
Jul 30, 2026	Wells Fargo	Overweight	N/A

Related Tools: Analyst Ratings Dashboard | View QURE Stock Page